---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-127673"
form_type: "8-K"
ticker: "HURA"
cik: "0001498382"
company_name: "TuHURA Biosciences, Inc./NV"
filed_at: "2024-11-15T23:59:59+00:00"
generated_at: "2026-05-29T23:43:36.509290+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# TuHURA raises CEO & CFO base salaries; grants options for 1.56M shares at $4.94

## Summary
- CEO Bianco base salary increased to $499,000; CFO Dearborn to $375,000, effective Jan 1, 2025.
- Bianco granted options for 1,065,990 shares; Dearborn for 489,848 shares, exercise price $4.94.
- Options vest in 1/3 annual installments over 3 years, 10-year term, under 2024 Equity Incentive Plan.
- Compensation Committee set salaries at ~80% of peer group 50th percentile.
- Approved form of stock option agreement, filed as Exhibit 10.1.

## SEC filing metadata
- accession: 0000950170-24-127673
- form_type: 8-K
- ticker: HURA
- cik: 0001498382
- company_name: TuHURA Biosciences, Inc./NV
- filed_at: 2024-11-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1498382/000095017024127673/0000950170-24-127673-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1498382/000095017024127673/hura-20241115.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-127673
- JSON: https://secwatch.observer/filing/0000950170-24-127673.json
- Plain text: https://secwatch.observer/filing/0000950170-24-127673.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.